Sinew Pharma Inc. (TPEX:6634)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.60
-0.10 (-0.30%)
Mar 10, 2026, 12:19 PM CST

Sinew Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2,4033,3924,7987,3265,6594,753
Upgrade
Market Cap Growth
-38.07%-29.30%-34.51%29.47%19.05%392.24%
Upgrade
Enterprise Value
1,3182,1853,4685,8954,3544,392
Upgrade
Last Close Price
33.7047.5567.70105.0082.0088.85
Upgrade
PS Ratio
---22335.55908.4510288.80
Upgrade
PB Ratio
2.102.833.635.023.6110.91
Upgrade
P/TBV Ratio
2.132.893.735.223.7713.49
Upgrade
EV/Sales Ratio
---17973.83699.019506.32
Upgrade
Debt / Equity Ratio
0.020.000.010.010.000.01
Upgrade
Net Debt / Equity Ratio
-0.95-0.97-0.96-0.95-0.94-0.77
Upgrade
Net Debt / EBITDA Ratio
7.897.987.7410.7920.065.20
Upgrade
Net Debt / FCF Ratio
11.1410.8810.1113.9824.905.49
Upgrade
Asset Turnover
---00.010.00
Upgrade
Quick Ratio
53.3443.4336.7860.5499.0822.69
Upgrade
Current Ratio
53.4043.4636.8160.5699.3622.71
Upgrade
Return on Equity (ROE)
-11.78%-11.93%-12.29%-9.26%-9.14%-27.13%
Upgrade
Return on Assets (ROA)
-8.07%-8.15%-8.17%-6.04%-5.79%-12.03%
Upgrade
Return on Capital Employed (ROCE)
-13.80%-14.10%-14.00%-10.10%-6.00%-19.20%
Upgrade
Earnings Yield
-5.90%-4.43%-3.56%-1.91%-1.62%-1.73%
Upgrade
FCF Yield
-4.06%-3.13%-2.61%-1.35%-1.05%-1.29%
Upgrade
Buyback Yield / Dilution
-0.12%-1.21%-1.68%-16.47%-19.41%-30.28%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.